What one share of Provectus Biopharmaceuticals holds
Provectus Biopharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.01 |
|---|---|
| Cash and investments | $0.00 |
| Debt | $0.00 |
| Book value | −$0.01 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2012 | $0.00 | −$0.11 | $0.00 | −$0.10 | — | $0.04 |
| 2013 | $0.00 | −$0.22 | $0.00 | −$0.07 | — | $0.04 |
| 2014 | $0.00 | −$0.06 | $0.00 | −$0.08 | — | $0.14 |
| 2015 | $0.00 | −$0.13 | $0.00 | −$0.09 | — | $0.08 |
| 2016 | — | −$0.12 | — | — | — | $0.01 |
| 2017 | — | −$0.04 | $0.00 | −$0.03 | — | −$0.03 |
| 2018 | — | −$0.02 | — | — | — | −$0.05 |
| 2019 | — | −$0.02 | — | — | — | −$0.06 |
| 2020 | — | −$0.02 | — | — | — | −$0.08 |
| 2021 | — | −$0.01 | — | — | — | −$0.01 |
| 2022 | $0.00 | −$0.01 | — | — | — | −$0.01 |
| 2023 | $0.00 | −$0.01 | — | — | — | −$0.02 |
| 2024 | $0.00 | −$0.01 | — | — | — | −$0.01 |
| 2025 | $0.00 | −$0.01 | — | — | — | −$0.01 |
Common questions about Provectus Biopharmaceuticals
How much does one share of Provectus Biopharmaceuticals earn?
Over the last 12 months, Provectus Biopharmaceuticals lost $0.01 for each share.
Does Provectus Biopharmaceuticals pay a dividend?
Provectus Biopharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Provectus Biopharmaceuticals’s book value per share?
Provectus Biopharmaceuticals’s book value is negative (−$0.01 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Provectus Biopharmaceuticals have?
Each share of Provectus Biopharmaceuticals has $0.00 of cash and investments and $0.00 of debt, as of June 30, 2026.
Has Provectus Biopharmaceuticals bought back shares?
Provectus Biopharmaceuticals’s share count rose about 272% from 2012 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.